Cytosorbents (NASDAQ:CTSO) Receives Buy Rating from D. Boral Capital
Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a $10.00 price target on the medical research company’s stock. Separately, StockNews.com started coverage on shares of Cytosorbents in a research report on Wednesday, March […]
Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They presently have a $10.00 price target on the medical research company’s stock. Separately, StockNews.com started coverage on shares of Cytosorbents in a research report on Wednesday, March […]
